Vaccine equity: a key to global economic recovery

Rohini Ghosh, Arabinda Ghosh


Background: The spread of severe acute respiratory syndrome coronavirus- 2 (SARS-CoV-2), the causative agent of coronavirus 2019 (COVID-19), has resulted in an unprecedented global public health and economic crisis. The cumulative number of cases is now over 200 million and the number of deaths exceeds 4.2 million. COVID-19 vaccination provides hope for an end to the pandemic, if and only if there would be equal access and optimal uptake in all countries around the world.

Methods: The study on nine selected countries corroborates the relative importance of vaccination rate in reducing daily death as percentage of confirmed COVID- 19 cases.

Results: Vaccination data has brought forth the gaping disparity in the process whereby lower income group countries with 8.6 percent of world population have received 0.3 percent of total vaccine dose as against high income countries with 15.7 percent of global population and have received 29.0.

Conclusions: Spending for vaccination should be considered as an investment instead of expenditure. 


COVID-19, Vaccination, Economic recovery, Equity

Full Text:



Cem C, Demiralp S, Kalemli-Özcan S, Yesiltas S, Yildirim MA. 2020. COVID-19 and Emerging Markets: An Epidemiological Model with International Production Networks and Capital Flows. NBER. 27191.

McKibbin W, Fernando R. The economic impact of COVID-19. In Economics in the Time of COVID-19; CEPR Press: London, UK. 2020;45-51.

World Health Organization. (2020d). WHO Director-General's opening remarks at the media briefing on COVID19 - 11 March 2020. Available at: Accessed on 13 March 2021.

Maliszewska M, Mattoo A, Van Der Mensbrugghe D. The potential impact of COVID-19 on GDP and trade: A preliminary assessment, Policy Research Working Paper 9211. The World Bank. 2020.

Nistha, S Shad MY, Ulvi O, Khan MH, Karamehic-Muratovic A, Uyen-Sa DT. 2020. The impact of COVID-19 on globalization. One Health. 2020;11:100180.

Bloom E. Potential economic impact of an Avian Flu pandemic on Asia. ERD Policy Brief Series No. 42. Asian Development Bank, Manila. 2005. Accessed on 20 March 2021.

Keogh-Brown MR, Smith RD. The economic impact of SARS: how does the reality match the predictions? Health Policy. 2008;88 (1):110-20.

McKibbin W, Fernando R. The global macroeconomic impacts of COVID-19: Seven scenarios (CAMA Working paper 19/2020). Australian National University. 2020.

Gossling S, Scott D, Hall CM Pandemics, tourism and global change: A rapid assess- € ment of COVID-19. Journal of Sustainable Tourism. 2020.

Dev MS, Sengupta R. Covid-19: Impact on the Indian economy," Indira Gandhi Institute of Development Research, Mumbai Working Papers 2020-013, Indira Gandhi Institute of Development Research, Mumbai, India. 2020.

Steenblock C, Todorov V, Kanczkowski W. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis. Mol Psychiatry. 2020.

Tisdell CA. Economic, social and political issues raised by the COVID-19 pandemic. Econ. Anal. Pol. 2020;68:17-28.

Fakhruddin B, Blanchard K, Ragupathy D. Are we there yet? The transition from response to recovery for the COVID-19 pandemic Prog Disaster Sci. 2020;100102

International Monetary Fund. World Economic Outlook Update. 2021; Washington, DC, USA. 2021. Available at: Accessed on 20 March 2021.

Randolph HE, Barreiro LB. Herd immunity: understanding COVID-19 Immunity. 2020;52(5):737-41.

Fine P, Eames K, Heymann DL. “Herd immunity”: a rough guide. Clin Infect Dis. 2011;52:911-6.

Read JM; Bridgen JRE, Cummings DAT, Ho A, Jewell CP. Novel coronavirus 2019-nCoV: Early estimation of epidemiological parameters and epidemic predictions. bioRxiv. 2020.

Lambert H, Gupte J, Fletcher H Hammond L, Lowe N, Pelling M et al. 2020. COVID-19 as a global challenge: towards an inclusive and sustainable future. Lancet Planet. Heal. 2020;4:e312-4.

Ndwandwe D, Wiysonge CS. COVID-19 vaccines. Current Opinion in Immunology. 2021;71:111-6.

Wouters OJ, Shadlen KC, Salcher-Konrad M. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021.

Forman R, Shah S, Jeurissen P, Jit M, Mossialos E. COVID-19 vaccine challenges: What have we learned so far and what remains to be done? Health Policy. 2021;125:553-67.

So AD, Woo J. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. BMJ 2020; 371: m4750.